XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.23.3

Earnings per Share (EPS) | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Earnings per Share (EPS) | Earnings per Share (EPS) The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(In thousands, except per share amounts) |  | 2023 |  | 2022 |  | 2023 |  | 2022
Net income |  | $ | 177,959 |  |  | $ | 178,051 |  |  | $ | 521,019 |  |  | $ | 683,987 |
Basic weighted average shares outstanding |  | 105,979 |  |  | 106,870 |  |  | 106,387 |  |  | 107,314 |
Dilutive effect of nonvested shares |  | 1,046 |  |  | 467 |  |  | 845 |  |  | 418 |
Diluted weighted average shares outstanding |  | 107,025 |  |  | 107,337 |  |  | 107,232 |  |  | 107,732 |
Basic earnings per share |  | $ | 1.68 |  |  | $ | 1.67 |  |  | $ | 4.90 |  |  | $ | 6.37 |
Diluted earnings per share |  | $ | 1.66 |  |  | $ | 1.66 |  |  | $ | 4.86 |  |  | $ | 6.35 |
There were 65,435 and 10,417 antidilutive shares for the three months ended September 30, 2023 and 2022, respectively, and 64,108 and 90,413 antidilutive shares for the nine months ended September 30, 2023 and 2022, respectively. Nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. The 2023, 2022 and 2021 performance-based share awards vest based upon our compounded annual book value per share growth percentage and relative total shareholder return during a three-year performance period. The performance-based share awards granted in years before 2021 vest based upon our compounded annual book value per share growth percentage during a three-year performance period. The following table summarizes the performance-based shares issuable if the reporting date was the end of the contingency period.
|  | 2023 Performance-Based Grants |  | 2022 Performance-Based Grants |  | 2021 Performance-Based Grants |  | 2020 Performance-Based Grants
Reporting Date |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target |  | As a Percent of Shares Issued |  | Percent Issuable Relative to Target and Shares Issued
September 30, 2023 |  | 200% |  | 100% |  | 200% |  | 100% |  | 157% |  | 78.5% |  |
September 30, 2022 |  |  |  |  |  | 146% |  | 73% |  | 100% |  | 50% |  | 100%

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration